Back to top

Neuren Pharmaceuticals Limited (NURPF) Receives a Buy from Macquarie

Macquarie analyst maintained a Buy rating on Neuren Pharmaceuticals Limited today and set a price target of A$23.00. In a report released today, Be...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NewMarket Corporation (NEU)